Advantage of using both anionic and zwitterionic phospholipid antigens for the detection of antiphospholipid antibodies

American Journal of Clinical Pathology

Volumn 106, Issue 4, 1996, Pages 549-554

  Laroche, Pascale ^a   Berard, Madeleine ^b   Rouquette, Anne Marie ^c   Desgruelle, Chantal ^c   Boffa, Marie Claire ^b  

^a Biomedical Diagnostics   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔPITAL TENON   (France)

Author keywords

Anticardiolipin antibodies; Antiphosphatidylethanolamine antibodies; Antiphosphatidylinositol antibodies; Antiphosphatidylserine antibodies; Antiphospholipid antibodies; Recurrent fetal losses; Thrombotic events

Indexed keywords

AMPHOLYTE; ANION; ANTIGEN; CARDIOLIPIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY;

ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OPTICAL DENSITY; PRIORITY JOURNAL;

EID: 0029767835     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/106.4.549     Document Type: Article

References (37)

1. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985;313:1322-1326.
2. Triplett DA. Laboratory diagnosis of lupus anticoagulants. Semin Thromb Haemost 1990;16:182-192.
3. Soulier JP, Boffa MC. Avortements à répétition, thromboses et anticoagulant circulant antithromboplastine. Trois observations. Nouv Presse Méd 1980;9:859-864.
4. Hughes GR, Harris EN, Gharavi A. The anticardiolipin syndrome. J Rheumatol 1986;13:486-488.
5. Asherson RA, Khamashta MA, Ordi-Ros J. The "primary" antiphospholipid syndrome: Major clinical and serological features. Medicine 1989;68:366-374.
6. Piette JC, Wechsler B, Blétry O, et al. Antiphospholipid syndrome. The clinician's point of view. Ann Méd Interne (Paris) 1992;143:392-395.
7. Hughes GR. The antiphospholipid syndrome: Ten years on. Lancet 1993;7:341-344.
8. Harris EN, Asherson RA, Gharavi AE, et al. Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol 1985;59:227-230.
9. Triplett DA. Clinical significance of antiphospholipid antibodies. Thromb Haemost 1988;10:2-10.
10. Weinstein C, Miller MH, Axtens R, Buchanan R, Littlejohn GO. Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 1987;123:596-600.
11. Naldi L, Locati F, Marchesi L, et al. Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: A case control study. Ann Rheum Dis 1993;52:219-222.
12. Francès C, Tribout B, Boisnic S, et al. Cutaneous necrosis associated with the lupus anticoagulant. Dermatologica 1989;178: 194-200.
13. Stephanson EA, Niemi KM, Jouhikainen T, Vaarala O, Palosuo T. Lupus anticoagulant and the skin. Acta Derm Venereol 1991;71:416-422.
14. Loizou S, McCrea JD, Rudge AC, et al. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantitation of results. Clin Exp Immunol 1985;2:738-745.
15. Harris EN, Loizou S, Englert H, et al. Anticardiolipin antibodies and lupus anticoagulant. Lancet 1984;2:52-67.
16. Branch DW, Rote NS, Scott JR. The demonstration of the lupus anticoagulant by an enzyme-linked immunosorbent assay (ELISA). Clin Immunol Immunopathol 1986;39:296-307.
17. 1 (apolipoprotein H). Proc Natl Acad Sci USA 1990;87: 4120-4124.
18. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-1547.
19. Oosting JD, Dersken RH, Bobbink IW, et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: An explanation for their pathogenic mechanisms? Blood 1993;81:2618-2625.
20. Matsuda J, Saitoh N, Gohchi K, et al. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am J Haematol 1994;47:56-58.
21. Sugi T, McIntyre JA. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995;86: 3083-3089.
22. Harris EN, Gharavi AE, Hugues GR. Anti-phospholipid antibodies. Clin Rheum Dis 1985;11:591-608.
23. Harris EN, Gharavi AE, Loizou S. Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol 1985;16:1-6.
24. Harris EN, Gharavi AE, Tineani A. Affinity purified anti-cardiolipin and anti-DNA antibodies. J Clin Lab Immunol 1985;17: 155-162.
25. Smirnov MD, Triplett DT, Comp PC, Esmon NL, Esmon CT. On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest 1995;95:309-316.
26. Triplett DA, Brandt JT, Musgrave KA, Orr CA. The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 1988;259:550-554.
27. Alarcon-Segovia D, Cabrai AR. Functional and immunochemical heterogeneity of antiphospholipid antibodies: A classification. J Rheumatol 1992;19:1166-1169.
28. Falcon RC. Antiphosphatidylinositol antibodies as markers of the antiphospholipid syndrome. Thromb Haemost 1990;63:321-322.
29. Rote NS, Dostal-Johnson D, Branch DW. Antiphospholipid antibodies and recurrent pregnancy loss: Correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin. Am J Obstet Gynecol 1990;163:575-584.
30. Loizou S, Mackworth-Young CG, Cofiner C, Walport MJ. Heterogeneity of binding reactivity to different phospholipids from patients with systemic lupus erythematosus (SLE) and with syphilis. Clin Exp Immunol 1990;80:171-176.
31. Qamar T, Gharavi AE, Levy RA, Lockshin MD. Lysophosphatidylethanolamine is the antigen to which apparent antibody to phosphatidylethanolamine binds. J Clin Immunol 1990;10: 200-203.
32. Branch DW, Scott JR. Clinical implications of anti-phospholipid antibodies: The Utah experience. In: Harris EN, Exner T, Hugues G, Asherson RA, eds. Phospholipid Binding Antibodies. Boca Raton, FL: CRC Press, 1991, pp 335-353.
33. Branch DW, Rote NS, Dostal D, Scott JR. Association of lupus anticoagulant with antibody against phosphatidylserine. Clin Immunol Immunopathol 1987;42:63-75.
34. Weidmann CE, Wallace DJ, Peter JB, et al. Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol 1988;15:74-79.
35. Faiderbe S, Chagnaud JL, Wafflart J, Geffard M. Autoantibodies directed against membrane phospholipid in serum in patients with malignant tumors. C R Acad Sci III 1989;310:49-52.
36. Staub HL, Harris EN, Khamashta MH, et al. Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis. Ann Rheum Dis 1989;48:166-169.
37. Karmochkine M, Cacoub P, Piette JC, Godeau P, Boffa MC. Antiphospholipid antibody as the sole antiphospholipid antibody in systemic lupus erythematosus with thrombosis. Clin Exp Rheumatol 1992;10:603-605.